VAX-24

24-valent pneumococcal conjugate vaccine · Vaxcyte, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VAX-24, covering 2024-04-16 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants [Phase 2]

See pricing